1 completed, 1 recruiting. 2 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Privo Technologies: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study Evaluating the Safety and Efficacy of PRV111, PRV211, and PRV131 in Subjects With Oral and Lung Cancers PRV211 (Intraoperative Cisplatin System), PRV111 (Cisplatin Transmucosal System), PRV131 (Cisplatin Intratumoral Injectable) - Oral Squamous Cell Carcinoma | Phase 2 / Phase 3 | Recruiting | Privo Technologies | 40 | 2024-11-07 | 2026-04-23 |
| Safety and Efficacy Study of PRV111 in Subjects With Oral Squamous Cell Carcinoma PRV111 (Cisplatin Transmucosal System) - Oral Squamous Cell Carcinoma | Phase 1 / Phase 2 | Completed | Privo Technologies | 10 | 2018-06-19 | 2022-10-21 |
Squamous Cell Carcinoma of Head and Neck (2)
Cisplatin (2)
United States (2)
R44CA192875 (1)